CELC (celcuity.com) נכסים נקיים של החברה

Celcuity Inc. (CELC) is a promising player in targeted oncology, utilizing the CELx system for personalized therapy selection. The stock's price history confirms market interest, with the key metric standing at -0.01. However, the company faces uncertainty regarding clinical trial outcomes and a dependence on investment. Simultaneously, the business is implementing robotic systems to automate the routine processing of biomaterials in laboratories.

The development of innovative diagnostic tests for personalized cancer therapy enables Celcuity Inc. (CELC) to build capital by providing high-precision analytics to medical centers. By analyzing the firm's book capitalization, an investor can discern the difference between all of the issuer's assets and liabilities, allowing for an assessment of the business's real value and the degree of market price resilience to fundamental risks.